Canadian pharmaceutical industry alarmed after Trump floats 200 per cent tariff

News Room
By News Room 5 Min Read

WASHINGTON – Canada likely isn’t the main target of U.S. President Donald Trump’s threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril.

“Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,” said Canadian Generic Pharmaceutical Association president Jim Keon.

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *